HyperGam+CF polyclonal antibody targeting the mucoid exopolysaccharide that coats Pseu-domonas aeruginosa bacteria: Began jointly sponsored Phase II trial in th

Genzyme Corp. (GENZ), Cambridge, Mass.
Univax Biologics

Read the full 87 word article

How to gain access

Continue reading with a
two-week free trial.